PHI Company Profile (NASDAQ:PHIIK)

About PHI (NASDAQ:PHIIK)

PHI logoPHI, Inc. is engaged in transportation of personnel to, from, and among offshore platforms for customers engaged in the oil and gas exploration, development and production industry. The Company offers these services in various domestic and international markets. Most of its offshore flight operations are concentrated in the Gulf of Mexico. The Company operates through three segments: Oil and Gas, Air Medical, and Technical Services. The Company also provides air medical transportation for hospitals and for emergency service agencies. In addition, it performs helicopter maintenance and repair services, primarily to existing customers that own their own aircraft. It owns or operates approximately 265 aircraft domestically and internationally, of which, over 155 belongs to its Oil and Gas segment, over 104 belongs to Air Medical segment and over six are in to other operations. Its principal customers are integrated energy companies and independent exploration and production companies.

Industry, Sector and Symbol:
  • Sector: Transportation
  • Industry: Oil Related Services and Equipment
  • Sub-Industry: Oil & Gas Equipment & Services
  • Symbol: NASDAQ:PHIIK
  • CUSIP: 69336T20
  • Web: www.phihelico.com
Capitalization:
  • Market Cap: $183.1 million
  • Outstanding Shares: 15,798,000
Average Prices:
  • 50 Day Moving Avg: $11.96
  • 200 Day Moving Avg: $10.82
  • 52 Week Range: $8.09 - $18.45
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $583.99 million
  • Price / Sales: 0.31
  • Book Value: $36.97 per share
  • Price / Book: 0.31
Profitability:
  • EBITDA: $42.78 million
  • Net Margins: -6.94%
  • Return on Equity: -6.78%
  • Return on Assets: -2.82%
Debt:
  • Debt-to-Equity Ratio: 1.08%
  • Current Ratio: 7.97%
  • Quick Ratio: 6.73%
Misc:
  • Average Volume: 32,431 shs.
  • Beta: 1.11
  • Short Ratio: 3.46
 

Frequently Asked Questions for PHI (NASDAQ:PHIIK)

What is PHI's stock symbol?

PHI trades on the NASDAQ under the ticker symbol "PHIIK."

Who are some of PHI's key competitors?

Who are PHI's key executives?

PHI's management team includes the folowing people:

  • Al A. Gonsoulin Jr., Chairman of the Board, Chief Executive Officer
  • Lance F. Bospflug, President, Chief Operating Officer, Director
  • Trudy P. McConnaughhay, Chief Financial Officer, Secretary
  • James Hinch, Chief Administrative Officer
  • David F. Stepanek, Chief Commercial Officer
  • Charles Russell Luigs, Independent Director
  • Richard Herman Matzke, Independent Director
  • Thomas H. Murphy, Independent Director

Who owns PHI stock?

PHI's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Skylands Capital LLC (0.11%). Company insiders that own PHI stock include David F Stepanek and Lance F Bospflug. View Institutional Ownership Trends for PHI.

Who sold PHI stock? Who is selling PHI stock?

PHI's stock was sold by a variety of institutional investors in the last quarter, including Skylands Capital LLC. View Insider Buying and Selling for PHI.

How do I buy PHI stock?

Shares of PHI can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PHI's stock price today?

One share of PHI stock can currently be purchased for approximately $11.59.


MarketBeat Community Rating for PHI (NASDAQ PHIIK)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  92
MarketBeat's community ratings are surveys of what our community members think about PHI and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for PHI (NASDAQ:PHIIK) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for PHI (NASDAQ:PHIIK)
Price Target History for PHI (NASDAQ:PHIIK)
Analysts' Ratings History for PHI (NASDAQ:PHIIK)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for PHI (NASDAQ:PHIIK)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for PHI (NASDAQ:PHIIK)
Current Year EPS Consensus Estimate: $0.90 EPS

Dividends

Dividend History for PHI (NASDAQ:PHIIK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for PHI (NASDAQ:PHIIK)
Insider Ownership Percentage: 16.66%
Institutional Ownership Percentage: 62.24%
Insider Trades by Quarter for PHI (NASDAQ:PHIIK)
Institutional Ownership by Quarter for PHI (NASDAQ:PHIIK)
Insider Trades by Quarter for PHI (NASDAQ:PHIIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/21/2017David F StepanekInsiderSell7,050$12.65$89,182.50View SEC Filing  
8/16/2016David F StepanekInsiderSell1,070$19.00$20,330.00View SEC Filing  
12/4/2015Lance F. BospflugCOOBuy20,000$20.35$407,000.00View SEC Filing  
6/4/2015Alton Anthony Gonsoulin JrCEOBuy3,000$34.43$103,290.00View SEC Filing  
8/22/2014David F StepanekInsiderSell1,700$41.50$70,550.00View SEC Filing  
5/10/2013Didier KellerDirectorBuy3,000$34.27$102,810.00View SEC Filing  
5/9/2013Didier KellerDirectorBuy3,000$34.37$103,110.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for PHI (NASDAQ:PHIIK)
Latest Headlines for PHI (NASDAQ:PHIIK)
Source:
Loading headlines, please wait.

Social

Chart

PHI (PHIIK) Chart for Tuesday, October, 24, 2017

This page was last updated on 10/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.